Sanara MedTech (SMTI) director Major received 4,846 shares
Insider transactions reported
Eric D Major (director at Sanara MedTech Inc., SMTI) reported that they received 4,846 shares on Jun 4, 2026. After these transactions the filing shows 14,232 shares held directly.
- Reporting person
- Major Eric D
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Grant or award (A) | Common Stock1 | +4,846 | - | - | 14,232 direct |
Holdings before and after
- Common Stock: 9,386 to 14,232 direct
Footnotes from the filing
- 1. Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer ) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 4, 2027, provided that the reporting person is providing certain services to the Issuer through such date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Major report in this SMTI Form 4?
Eric D Major (director at Sanara MedTech Inc., SMTI) reported that they received 4,846 shares on Jun 4, 2026. After these transactions the filing shows 14,232 shares held directly.
How many SMTI shares does Major hold after this filing?
The filing shows 14,232 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for SMTI
Across the 12 sessions after earlier SMTI headlines, the stock closed higher 7 times and lower 5 times, with a median move of 3.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | SMTI | SPY |
|---|---|---|---|
| May 12, 2026 | Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited) | +13.4% | -0.2% |
| Apr 15, 2026 | Lake Street initiated coverage on Sanara MedTech with a new price target | +8.1% | +0.8% |
| Apr 14, 2026 | Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026 | +5.2% | +1.2% |
| Mar 24, 2026 | Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance | -1.4% | -0.3% |
| Mar 11, 2026 | Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds | -0.5% | -0.1% |
| Mar 3, 2026 | Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 | +1.8% | -0.9% |
Earlier insider filings at SMTI
- Jun 6, 2026Director Ortwein Sara N was granted 4,616 shares, increasing direct ownership by 22% to 25,415 units (SEC Form 4)
- Jun 6, 2026Director Nixon Ronald T was granted 4,154 shares, increasing direct ownership by 6% to 68,196 units (SEC Form 4)
- Jun 6, 2026Director Desutter Robert Andrew was granted 5,539 shares, increasing direct ownership by 24% to 28,740 units (SEC Form 4)
- Jun 6, 2026Director Salamone Ann Beal was granted 4,154 shares, increasing direct ownership by 18% to 26,858 units (SEC Form 4)
- Jun 6, 2026Director Mack Roszell Iii was granted 5,308 shares, increasing direct ownership by 32% to 21,842 units (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Industrial Specialties
Follow SMTI and get a push notification the moment its next story breaks.